Request Free Sample ×
Inhalation Anesthesia Market Research Report-Forecast to 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Inhalation Anesthesia Market

ID: MRFR/HC/6587-HCR
200 Pages
Vikita Thakur
Last Updated: April 06, 2026

Inhalation Anesthesia Market Research Report By Application (General Surgery, Dental Surgery, Pediatric Surgery, Obstetric Surgery), By Product Type (Nitrous Oxide, Halothane, Isoflurane, Sevoflurane), By End Use (Hospitals, Outpatient Surgical Centers, Ambulatory Surgical Centers), By Route of Administration (Inhalation, Intravenous) and By Region (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Inhalation Anesthesia Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Million)
      1. 4.1.1 Surgical Procedures
      2. 4.1.2 Pain Management
      3. 4.1.3 Diagnostic Procedures
      4. 4.1.4 Emergency Care
    2. 4.2 Healthcare, BY End Use (USD Million)
      1. 4.2.1 Hospitals
      2. 4.2.2 Ambulatory Surgical Centers
      3. 4.2.3 Specialty Clinics
      4. 4.2.4 Research Institutions
    3. 4.3 Healthcare, BY Type of Anesthetic (USD Million)
      1. 4.3.1 Volatile Anesthetics
      2. 4.3.2 Gaseous Anesthetics
      3. 4.3.3 Combination Anesthetics
    4. 4.4 Healthcare, BY Delivery Method (USD Million)
      1. 4.4.1 Mask Delivery
      2. 4.4.2 Endotracheal Tube Delivery
      3. 4.4.3 Laryngeal Mask Airway Delivery
    5. 4.5 Healthcare, BY Patient Demographics (USD Million)
      1. 4.5.1 Pediatric Patients
      2. 4.5.2 Adult Patients
      3. 4.5.3 Geriatric Patients
    6. 4.6 Healthcare, BY Region (USD Million)
      1. 4.6.1 North America
        1. 4.6.1.1 US
        2. 4.6.1.2 Canada
      2. 4.6.2 Europe
        1. 4.6.2.1 Germany
        2. 4.6.2.2 UK
        3. 4.6.2.3 France
        4. 4.6.2.4 Russia
        5. 4.6.2.5 Italy
        6. 4.6.2.6 Spain
        7. 4.6.2.7 Rest of Europe
      3. 4.6.3 APAC
        1. 4.6.3.1 China
        2. 4.6.3.2 India
        3. 4.6.3.3 Japan
        4. 4.6.3.4 South Korea
        5. 4.6.3.5 Malaysia
        6. 4.6.3.6 Thailand
        7. 4.6.3.7 Indonesia
        8. 4.6.3.8 Rest of APAC
      4. 4.6.4 South America
        1. 4.6.4.1 Brazil
        2. 4.6.4.2 Mexico
        3. 4.6.4.3 Argentina
        4. 4.6.4.4 Rest of South America
      5. 4.6.5 MEA
        1. 4.6.5.1 GCC Countries
        2. 4.6.5.2 South Africa
        3. 4.6.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 AbbVie (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Baxter International (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Fresenius Kabi (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Halocarbon Products Corporation (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Medi-Flex (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Piramal Enterprises (IN)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Smiths Medical (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Vyaire Medical (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY APPLICATION
    4. 6.4 US MARKET ANALYSIS BY END USE
    5. 6.5 US MARKET ANALYSIS BY TYPE OF ANESTHETIC
    6. 6.6 US MARKET ANALYSIS BY DELIVERY METHOD
    7. 6.7 US MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    8. 6.8 CANADA MARKET ANALYSIS BY APPLICATION
    9. 6.9 CANADA MARKET ANALYSIS BY END USE
    10. 6.10 CANADA MARKET ANALYSIS BY TYPE OF ANESTHETIC
    11. 6.11 CANADA MARKET ANALYSIS BY DELIVERY METHOD
    12. 6.12 CANADA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    13. 6.13 EUROPE MARKET ANALYSIS
    14. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
    15. 6.15 GERMANY MARKET ANALYSIS BY END USE
    16. 6.16 GERMANY MARKET ANALYSIS BY TYPE OF ANESTHETIC
    17. 6.17 GERMANY MARKET ANALYSIS BY DELIVERY METHOD
    18. 6.18 GERMANY MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    19. 6.19 UK MARKET ANALYSIS BY APPLICATION
    20. 6.20 UK MARKET ANALYSIS BY END USE
    21. 6.21 UK MARKET ANALYSIS BY TYPE OF ANESTHETIC
    22. 6.22 UK MARKET ANALYSIS BY DELIVERY METHOD
    23. 6.23 UK MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    24. 6.24 FRANCE MARKET ANALYSIS BY APPLICATION
    25. 6.25 FRANCE MARKET ANALYSIS BY END USE
    26. 6.26 FRANCE MARKET ANALYSIS BY TYPE OF ANESTHETIC
    27. 6.27 FRANCE MARKET ANALYSIS BY DELIVERY METHOD
    28. 6.28 FRANCE MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    29. 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
    30. 6.30 RUSSIA MARKET ANALYSIS BY END USE
    31. 6.31 RUSSIA MARKET ANALYSIS BY TYPE OF ANESTHETIC
    32. 6.32 RUSSIA MARKET ANALYSIS BY DELIVERY METHOD
    33. 6.33 RUSSIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    34. 6.34 ITALY MARKET ANALYSIS BY APPLICATION
    35. 6.35 ITALY MARKET ANALYSIS BY END USE
    36. 6.36 ITALY MARKET ANALYSIS BY TYPE OF ANESTHETIC
    37. 6.37 ITALY MARKET ANALYSIS BY DELIVERY METHOD
    38. 6.38 ITALY MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    39. 6.39 SPAIN MARKET ANALYSIS BY APPLICATION
    40. 6.40 SPAIN MARKET ANALYSIS BY END USE
    41. 6.41 SPAIN MARKET ANALYSIS BY TYPE OF ANESTHETIC
    42. 6.42 SPAIN MARKET ANALYSIS BY DELIVERY METHOD
    43. 6.43 SPAIN MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    44. 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    45. 6.45 REST OF EUROPE MARKET ANALYSIS BY END USE
    46. 6.46 REST OF EUROPE MARKET ANALYSIS BY TYPE OF ANESTHETIC
    47. 6.47 REST OF EUROPE MARKET ANALYSIS BY DELIVERY METHOD
    48. 6.48 REST OF EUROPE MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    49. 6.49 APAC MARKET ANALYSIS
    50. 6.50 CHINA MARKET ANALYSIS BY APPLICATION
    51. 6.51 CHINA MARKET ANALYSIS BY END USE
    52. 6.52 CHINA MARKET ANALYSIS BY TYPE OF ANESTHETIC
    53. 6.53 CHINA MARKET ANALYSIS BY DELIVERY METHOD
    54. 6.54 CHINA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    55. 6.55 INDIA MARKET ANALYSIS BY APPLICATION
    56. 6.56 INDIA MARKET ANALYSIS BY END USE
    57. 6.57 INDIA MARKET ANALYSIS BY TYPE OF ANESTHETIC
    58. 6.58 INDIA MARKET ANALYSIS BY DELIVERY METHOD
    59. 6.59 INDIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    60. 6.60 JAPAN MARKET ANALYSIS BY APPLICATION
    61. 6.61 JAPAN MARKET ANALYSIS BY END USE
    62. 6.62 JAPAN MARKET ANALYSIS BY TYPE OF ANESTHETIC
    63. 6.63 JAPAN MARKET ANALYSIS BY DELIVERY METHOD
    64. 6.64 JAPAN MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    65. 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    66. 6.66 SOUTH KOREA MARKET ANALYSIS BY END USE
    67. 6.67 SOUTH KOREA MARKET ANALYSIS BY TYPE OF ANESTHETIC
    68. 6.68 SOUTH KOREA MARKET ANALYSIS BY DELIVERY METHOD
    69. 6.69 SOUTH KOREA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    70. 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
    71. 6.71 MALAYSIA MARKET ANALYSIS BY END USE
    72. 6.72 MALAYSIA MARKET ANALYSIS BY TYPE OF ANESTHETIC
    73. 6.73 MALAYSIA MARKET ANALYSIS BY DELIVERY METHOD
    74. 6.74 MALAYSIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    75. 6.75 THAILAND MARKET ANALYSIS BY APPLICATION
    76. 6.76 THAILAND MARKET ANALYSIS BY END USE
    77. 6.77 THAILAND MARKET ANALYSIS BY TYPE OF ANESTHETIC
    78. 6.78 THAILAND MARKET ANALYSIS BY DELIVERY METHOD
    79. 6.79 THAILAND MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    80. 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
    81. 6.81 INDONESIA MARKET ANALYSIS BY END USE
    82. 6.82 INDONESIA MARKET ANALYSIS BY TYPE OF ANESTHETIC
    83. 6.83 INDONESIA MARKET ANALYSIS BY DELIVERY METHOD
    84. 6.84 INDONESIA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    85. 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
    86. 6.86 REST OF APAC MARKET ANALYSIS BY END USE
    87. 6.87 REST OF APAC MARKET ANALYSIS BY TYPE OF ANESTHETIC
    88. 6.88 REST OF APAC MARKET ANALYSIS BY DELIVERY METHOD
    89. 6.89 REST OF APAC MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    90. 6.90 SOUTH AMERICA MARKET ANALYSIS
    91. 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
    92. 6.92 BRAZIL MARKET ANALYSIS BY END USE
    93. 6.93 BRAZIL MARKET ANALYSIS BY TYPE OF ANESTHETIC
    94. 6.94 BRAZIL MARKET ANALYSIS BY DELIVERY METHOD
    95. 6.95 BRAZIL MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    96. 6.96 MEXICO MARKET ANALYSIS BY APPLICATION
    97. 6.97 MEXICO MARKET ANALYSIS BY END USE
    98. 6.98 MEXICO MARKET ANALYSIS BY TYPE OF ANESTHETIC
    99. 6.99 MEXICO MARKET ANALYSIS BY DELIVERY METHOD
    100. 6.100 MEXICO MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    101. 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
    102. 6.102 ARGENTINA MARKET ANALYSIS BY END USE
    103. 6.103 ARGENTINA MARKET ANALYSIS BY TYPE OF ANESTHETIC
    104. 6.104 ARGENTINA MARKET ANALYSIS BY DELIVERY METHOD
    105. 6.105 ARGENTINA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
    108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE OF ANESTHETIC
    109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY DELIVERY METHOD
    110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    111. 6.111 MEA MARKET ANALYSIS
    112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY END USE
    114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY TYPE OF ANESTHETIC
    115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY DELIVERY METHOD
    116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY END USE
    119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY TYPE OF ANESTHETIC
    120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY DELIVERY METHOD
    121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    122. 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
    123. 6.123 REST OF MEA MARKET ANALYSIS BY END USE
    124. 6.124 REST OF MEA MARKET ANALYSIS BY TYPE OF ANESTHETIC
    125. 6.125 REST OF MEA MARKET ANALYSIS BY DELIVERY METHOD
    126. 6.126 REST OF MEA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
    128. 6.128 RESEARCH PROCESS OF MRFR
    129. 6.129 DRO ANALYSIS OF HEALTHCARE
    130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
    133. 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    134. 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    135. 6.135 HEALTHCARE, BY END USE, 2024 (% SHARE)
    136. 6.136 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
    137. 6.137 HEALTHCARE, BY TYPE OF ANESTHETIC, 2024 (% SHARE)
    138. 6.138 HEALTHCARE, BY TYPE OF ANESTHETIC, 2024 TO 2035 (USD Million)
    139. 6.139 HEALTHCARE, BY DELIVERY METHOD, 2024 (% SHARE)
    140. 6.140 HEALTHCARE, BY DELIVERY METHOD, 2024 TO 2035 (USD Million)
    141. 6.141 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
    142. 6.142 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
    143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.2.2 BY END USE, 2025-2035 (USD Million)
      3. 7.2.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.2.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.2.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.3.2 BY END USE, 2025-2035 (USD Million)
      3. 7.3.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.3.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.3.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.4.2 BY END USE, 2025-2035 (USD Million)
      3. 7.4.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.4.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.4.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.5.2 BY END USE, 2025-2035 (USD Million)
      3. 7.5.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.5.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.5.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.6.2 BY END USE, 2025-2035 (USD Million)
      3. 7.6.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.6.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.6.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.7.2 BY END USE, 2025-2035 (USD Million)
      3. 7.7.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.7.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.7.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.8.2 BY END USE, 2025-2035 (USD Million)
      3. 7.8.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.8.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.8.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.9.2 BY END USE, 2025-2035 (USD Million)
      3. 7.9.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.9.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.9.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.10.2 BY END USE, 2025-2035 (USD Million)
      3. 7.10.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.10.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.10.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.11.2 BY END USE, 2025-2035 (USD Million)
      3. 7.11.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.11.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.11.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.12.2 BY END USE, 2025-2035 (USD Million)
      3. 7.12.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.12.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.12.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.13.2 BY END USE, 2025-2035 (USD Million)
      3. 7.13.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.13.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.13.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.14.2 BY END USE, 2025-2035 (USD Million)
      3. 7.14.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.14.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.14.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.15.2 BY END USE, 2025-2035 (USD Million)
      3. 7.15.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.15.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.15.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.16.2 BY END USE, 2025-2035 (USD Million)
      3. 7.16.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.16.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.16.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.17.2 BY END USE, 2025-2035 (USD Million)
      3. 7.17.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.17.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.17.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.18.2 BY END USE, 2025-2035 (USD Million)
      3. 7.18.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.18.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.18.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.19.2 BY END USE, 2025-2035 (USD Million)
      3. 7.19.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.19.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.19.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.20.2 BY END USE, 2025-2035 (USD Million)
      3. 7.20.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.20.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.20.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.21.2 BY END USE, 2025-2035 (USD Million)
      3. 7.21.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.21.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.21.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.22.2 BY END USE, 2025-2035 (USD Million)
      3. 7.22.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.22.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.22.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.23.2 BY END USE, 2025-2035 (USD Million)
      3. 7.23.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.23.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.23.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.24.2 BY END USE, 2025-2035 (USD Million)
      3. 7.24.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.24.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.24.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.25.2 BY END USE, 2025-2035 (USD Million)
      3. 7.25.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.25.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.25.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.26.2 BY END USE, 2025-2035 (USD Million)
      3. 7.26.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.26.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.26.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.27.2 BY END USE, 2025-2035 (USD Million)
      3. 7.27.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.27.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.27.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.28.2 BY END USE, 2025-2035 (USD Million)
      3. 7.28.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.28.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.28.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.29.2 BY END USE, 2025-2035 (USD Million)
      3. 7.29.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.29.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.29.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.30.2 BY END USE, 2025-2035 (USD Million)
      3. 7.30.3 BY TYPE OF ANESTHETIC, 2025-2035 (USD Million)
      4. 7.30.4 BY DELIVERY METHOD, 2025-2035 (USD Million)
      5. 7.30.5 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Healthcare Market Segmentation

Healthcare By Application (USD Million, 2025-2035)

  • Surgical Procedures
  • Pain Management
  • Diagnostic Procedures
  • Emergency Care

Healthcare By End Use (USD Million, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research Institutions

Healthcare By Type of Anesthetic (USD Million, 2025-2035)

  • Volatile Anesthetics
  • Gaseous Anesthetics
  • Combination Anesthetics

Healthcare By Delivery Method (USD Million, 2025-2035)

  • Mask Delivery
  • Endotracheal Tube Delivery
  • Laryngeal Mask Airway Delivery

Healthcare By Patient Demographics (USD Million, 2025-2035)

  • Pediatric Patients
  • Adult Patients
  • Geriatric Patients

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓